Home
Partners
Opportunistic & Coinfections
Side Effects
Treatment
Publications
Tools
Glossary
 
Home

        

 


An online resource for health care professionals in the field of HIV,
providing access to...


  • The latest information on ARV side effects and toxicity
  • Easy-to-understand review articles
  • Published research papers and guidance documents on issues of ARV toxicity
  • Risk evaluation tools
  •  

      The HIV pharmacovigilance website is part of a project funded by the Seventh Framework Programme (FP-7) of the Research Directorate of the European Commission (EC).

    Photo courtesy of O. O'hanlon (AVERT)


                        




    News

    FDA approves Egrifta to Treat Lipodystrophy in HIV Patients
    Egrifta, the first FDA-approved treatment for lipodystrophy, is a growth hormone releasing factor (GRF) drug that is administered in a once-daily injection.


    FDA Safety Announcement:
    Invirase (saquinavir) labels now contain updated risk information on abnormal heart rhythms.


    Monitoring Medicines Website
    The ‘Monitoring Medicines’ website has now been launched.

    Terms Of Use | Privacy Statement | Login Copyright 2009 by DotNetNuke Corporation